Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P319: Trough levels of adalimumab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn’s disease on adalimumab maintenance therapy

ECCO '19 Copenhagen

Year: 2019
Authors:

E. H. Oh*1, A-R. Yoon2, S. H. Park3, J. Kim1, N. Ham1, E. M. Song1, S. W. Hwang1,2, S. H. Park1,2, D-H. Yang1, J-S. Byeon1, S-J. Myung1, S-K. Yang1,2, B. D. Ye1,2

1Asan Medical Center, Gastroenterology, Seoul, South Korea, 2Asan Medical Center, Inflammatory Bowel Disease Center, Seoul, South Korea, 3Asan Medical Center, Radiology, Seoul, South Korea

P320: High Cytomegalovirus DNA load in mucosal biopsies predicts steroid failure as well as colectomy in acute severe ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Jain1, D. Namdeo1, S. Kedia1, P. Sahu1, P. Das1, P. Sahni1, N. R. Dash1, S. Pal1, G. Makharia1, L. Dar1, V. Ahuja*1

1All India Institute of Medical Sciences, New Delhi, India

P321: On effectiveness, safety, and TDM of thioguanine in a cohort of 274 patients with IBD, intolerant for conventional thiopurines

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Simsek*1, D. Deben2, C. S. Horjus3, M. Seinen1, C. J. Mulder1, D. R. Wong2, N. K. de Boer1, A. A. van Bodegraven4

1Amsterdam UMC, VU Medical Center, Gastroenterology and Hepatology, Amsterdam, The Netherlands, 2Zuyderland Medical Center, Clinical Pharmacy, Sittard-Geleen-Heerlen, The Netherlands, 3Rijnstate Hospital, Gastroenterology and Hepatology, Arnhem, The Netherlands, 4Zuyderland Medical Center, Gastroenterology and Hepatology, Sittard-Geleen-Heerlen, The Netherlands

P322: Disease-related worries and concerns in patients with ulcerative colitis: 1-year data from ICONIC

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Ghosh*1, F. Casellas2, C. O’Shea3, K. Kligys4, J. Petersson4, L. Peyrin-Biroulet5

1University of Birmingham, Birmingham, UK, 2Crohn-Colitis Care Unit (UACC), Hospital Universitari Vall, Vall d'Hebron, Spain, 3AbbVie Ltd., Dublin, Ireland, 4AbbVie Inc., North Chicago, Illinois, USA, 5University of Lorraine, Nancy, France

P323: Prognostic factors for long-term adalimumab treatment

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Fumery*1, N. Duveau2, C. Perignon3, G. Lepeut4, A. Lahaye1, G. Le Baut1, C. Roussillon3, C. Yzet1, J. Loreau1, P. Wils4, M. Nachury4, B. Pariente4, S. Viennot3

1Amiens Hospital, Gastroenterology, Amiens, France, 2Roubaix Hospital, Gastroenterology, Roubaix, France, 3Caen Hospital, Gastroenterology, Caen, France, 4Claude Huriez Hospital, Lille University, Gastoenterology, Lille, France

P324: Tuberculosis infection under anti-TNF therapy – should we be looking for it?

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Xavier*1,2,3, T. Cúrdia Gonçalves1,2,3, F. Dias de Castro1,2,3, J. Magalhães1,2,3, M. J. Moreira1,2,3, J. Cotter1,2,3

1Hospital da Senhora da Oliveira, Guimarães, Gastroenterology, Guimarães, Portugal, 2School of Medicine, University of Minho, Braga, Portugal, 3ICVS/3B’s Associate Laboratory, University of Minho, Braga/Guimarães, Portugal

P325: Integrating efficacy and safety of vedolizumab and other advanced therapies for the treatment of ulcerative colitis: Results from a network meta-analysis

ECCO '19 Copenhagen

Year: 2019
Authors:

V. Jairath*1, K. Lasch2, K. Chan3, S. Kanters4, J. Jansen4, C. Agboton5, H. Patel6

1Western University, London, ON, Canada, 2Takeda Pharmaceuticals International, Deerfield, IL, USA, 3Precision Xtract, Vancouver, BC, Canada, 4Precision Xtract, Oakland, CA, USA, 5Takeda Pharmaceuticals International AG, Zurich, Switzerland, 6Takeda Pharmaceuticals International, Deerfield, USA

P326: Audit and review of infliximab therapeutic drug monitoring and prescribing practices in paediatric inflammatory bowel disease (IBD) patients

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Lang*1

1Our Lady's Children's Hospital Crumlin, Pharmacy, Dublin, Ireland

P327: Segmental colectomy for ulcerative colitis: a new paradigm? A multi-centric study in 72 patients

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Frontali*1, Y. Panis1, L. Cohen2, V. Bridoux3, P. Myrelid4, G. Sica5, G. Poggioli6, E. Espin7, L. Beyer-Berjot8, D. Laharie9, A. Spinelli10, P. Zerbib11, G. Sampietro12, M. Frasson13, E. Louis14, X. Treton2

1Beaujon Hospital, Colorectal Surgery, Clichy, France, 2Beaujon Hospital, Gastroenterology, Clichy, France, 3CHU Rouen, Digestive Surgery, Rouen, France, 4Linkoping Hospital, Digestive Surgery, Linkoping, Sweden, 5Policlinico Tor Vergata, Digestive Surgery, Roma, Italy, 6Policlinico Sant'Orsola-Malpighi, Digestive Surgery, Bologna, Italy, 7Hospital Universitari Val d'Hebron, Digestive Surgery, Barcelona, Spain, 8Hôpital Nord, Digestive Surgery, Marseille, France, 9CHU Bordeaux, Gastroenterology, Bordeaux, France, 10Humanitas Research Hospital, Colorectal Surgery, Rozzano - Milano, Italy, 11CHU Lille, Digestive Surgery, Lille, France, 12Ospedale L. Sacco, Chirurgia Generale 2, Milano, Italy, 13University Hospital La Fe, Digestive Surgery, Valencia, Spain, 14CHU Liege, Gastroenterology, Liege, France

P328: Low vitamin K, vitamin D and calcium dietary intake in IBD patients represents a potentially reversible risk factor for osteoporosis

ECCO '19 Copenhagen

Year: 2019
Authors:

N. S. Bertetti1, G. Burrelli Scotti1, M. T. Afferri1, V. Casali1, E. Cuofano1, C. Tortoriello1, A. De Carolis1, P. Vernia*1

1Sapienza University of Rome, Department of Internal Medicine and Medical Specialties, Gastroenterology, Rome, Italy

P329: Adalimumab therapeutic drug monitoring test validated for measuring ABP 501 biosimilar

ECCO '19 Copenhagen

Year: 2019
Authors:

M. B. Ruiz-Argüello1, A. Maguregui1, A. Martínez1, D. Nagore1

1Progenika Biopharma-Grifols, Derio, Spain

P330: A national survey on therapeutic education in inflammatory bowel disease by an association of caregivers and expert patients: French Association for Therapeutic Education in inflammatory bowel disease (AFEMI)

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Moreau1, E. Balez2, C. Devos3, X. Hébuterne4, M. Veltin5, M. Allez*6

1Rangueil Hospital and University, Gastroenterology, Toulouse, France, 2Afa Crohn RCH France, Nice, France, 3Afa Crohn RCH France, Paris, France, 4Nice Hospital and University, Gastroenterology, Nice, France, 5Nancy Brabois Regional University Hospital, Vandœuvre-lès-Nancy, France, 6Saint-Louis Hospital, Gastroenterology, Paris, France

P331: Real-world assessment of biological treatment of inflammatory bowel disease at an Austrian Referral Centre: the ULTIMATE study

ECCO '19 Copenhagen

Year: 2019
Authors:

H. P. Gröchenig*1, E. Walter2, A. Redl3, M. Bresztowanszky1, K. Steidl1, F. Siebert1, G. Novacek5

1Krankenhaus der Barmherzigen Brüder, Internal Medicine, St. Veit an der Glan, Austria, 2Institute for Pharmaeconomic Research, Vienna, Austria, 3Datamedrix GmbH, Vienna, Austria, 5Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Vienna, Austria

P332: Multinational comparisons of practices in overseas travel in Crohn’s disease and ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

K. Greveson*1, C. Inglis2, S. Ben-Horin3, S. Ghaly4, Y. Yunki5, R. Leong5

1Royal Free London NHS Foundation Trust, Centre for Gastroenterology, London, UK, 2The University of Notre Dame, Sydney, Australia, 3Sheba Medical Center,, IBD Service and Gastro-Immunology Laboratory Department of Gastroenterology, Tel-Hashomer,, Israel, 4St Vincents Hospital, Gastroenterology, Sydney, Australia, 5Concord General Repatriation Hospital, Department of Gastroenterology and Liver Services, Sydney, Australia

P333: Associations between multiple immunosuppressive treatments before surgery and surgical morbidity in patients with ulcerative colitis during the era of biologics

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Uchino*1, H. Ikeuchi1, T. Bando1, T. Chohno1, H. Sasaki1, Y. Horio1, R. Kuwahara1, T. Minagawa1, Y. Goto1

1Hyogo College of Medicine, Inflammatory Bowel Disease, Nishinomiya, Japan

P334: Chromoendoscopy is superior to white light endoscopy for the detection of advanced colonic neoplasia in patients with inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

K. O. Kim*1,2, M. Chiorean2

1Yeungnam University College of Medicine, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Daegu, South Korea, 2Virginia Mason Medical Center, Digestive Disease Institute, Seattle, USA

P335: Long-term follow-up of switching from original infliximab to infliximab biosimilar: real-world data

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Guerra Veloz*1, M. Belvis Jimenez1, T. Valdes Delgado1, L. Castro Laria1, B. Maldonado Pérez1, A. Benítez Roldán1, R. Perea Amarillo1, V. Merino Bohorquez2, M. A. Calleja Hernandez2, A. Caunedo Álvarez1, A. Vilches Arenas3, F. Argüelles-Arias1

1Virgen Macarena Hospital, Gastroenterology, Seville, Spain, 2Virgen Macarena Hospital, Pharmacy Unit, Seville, Spain, 3Virgen Macarena Hospital, Preventive Medicine and Public Health, Seville, Spain

P336: Behavioural treatment options for psychological comorbidities in patients with inflammatory bowel disease: a systematic literature review

ECCO '19 Copenhagen

Year: 2019
Authors:

L. Keefer1, R. Cheung*2, M. Bernauer3, D. Patel2, M. Dubinsky1

1Icahn School of Medicine at Mount Sinai, New York City, USA, 2Pfizer Inc., New York City, USA, 3Pharmerit International, Bethesda, USA

P337: Switching from originator infliximab to CT-P13: single-centre experience from the UK

ECCO '19 Copenhagen

Year: 2019
Authors:

A. P. Bhandare*1, B. Crooks1, G. B. Nigam1, J. K. Limdi1,2

1Pennine Acute Hospitals Trust, Gastroenterology, Manchester, UK, 2University of Manchester, Institute of Inflammation and Repair, Manchester, UK

P338: Long-term complications in patients with fistulising Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Vuyyuru*1, S. Kedia1, P. Sahu1, S. Bopanna1, S. Jain1, G. Makharia1, V. Ahuja1

1All India Institute Of Medical Sciences, Gastroenterology, New Delhi, India